As Denise Botcheos shares, the program fostered a “quiet, meaningful space focused on their growth,” allowing participants to openly address substance use, addiction, past traumas, and current risky behaviors in a safe environment. 

Prevention Point Philadelphia is proud to announce that a collaborative study with the Philadelphia College of Osteopathic Medicine (PCOM), led by Dr. Michelle R. Lent (pictured above), Professor at PCOM, was well-received at the College on Problems of Drug Dependence (CPDD) in New Orleans on June 17, 2025. This national recognition highlights the significant impact of the joint efforts of PPP with PCOM and a range of practitioners, including key insights from our team like Denise Botcheos, Director of Behavioral Health Services, in supporting individuals on their recovery journeys. 

The study, conducted last year, explored the feasibility and high acceptability of a manualized cognitive-behavioral therapy (CBT) program specifically tailored for individuals with opioid use disorder (OUD), delivered right here in a community-based harm-reduction setting. 

While the program emphasized strategies for reducing substance use, it also encouraged participants to build a supportive community, both formal and informal. This focus on fostering meaningful connections proved crucial, as ongoing substance use often stems from feelings of shame, loneliness, and isolation. Participants frequently feel as though loved ones have given up on them, leading to a harsh, self-critical self-image. Expanding their support networks was instrumental in addressing these feelings, as building strong, positive connections helped reduce isolation and support recovery.

The transformative changes observed in participants following the 12-week therapy program are truly inspiring. Key shifts included:

  • Engagement in Intensive Outpatient Programs (IOP): Some participants began attending IOP for the first time, marking a significant step in their recovery journey.
  • Addressing Legal Barriers: Participants confronted unresolved criminal charges, and program staff advocated on their behalf, resulting in dropped warrants and dismissed cases.
  • Medication-Assisted Treatment: Several participants started on long-acting injectable buprenorphine, aiding in sustained opioid use disorder treatment.
  • Relocation: Some participants moved out of Philadelphia to seek a fresh start in new communities.
  • Housing Stability: After years in shelters, one participant moved into permanent "housing-first" apartments, providing a stable foundation for continued progress in recovery.

The positive reception of Dr. Lent's presentation at the CPDD conference underscores the vital role that accessible, community-based behavioral health interventions play in addressing the opioid crisis. We are incredibly proud of this collaboration with PCOM and the tangible positive impact it has had on the lives of individuals striving for recovery. This study reinforces our commitment to providing innovative and compassionate care, demonstrating that with the right support, transformative change is possible.